Carin C. Lunenburg

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Severe fluoropyrimidine toxicity in older adults with cancer with DPYD wild type.

Severe fluoropyrimidine toxicity in older adults with cancer with DPYD wild type.

Journal: Fundamental & clinical pharmacology

Published: June 28, 2024

Discovering novel germline genetic variants linked to severe fluoropyrimidine-related toxicity in- and outside DPYD.

Discovering novel germline genetic variants linked to severe fluoropyrimidine-related toxicity in- and outside DPYD.

Journal: Genome medicine

Published: March 29, 2024

Survival of Patients With Cancer With DPYD Variant Alleles and Dose-Individualized Fluoropyrimidine Therapy-A Matched-Pair Analysis.

Survival of Patients With Cancer With DPYD Variant Alleles and Dose-Individualized Fluoropyrimidine Therapy-A Matched-Pair Analysis.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 28, 2023

Clinical Impact of Functional CYP2C19 and CYP2D6 Gene Variants on Treatment with Antidepressants in Young People with Depression: A Danish Cohort Study.

Clinical Impact of Functional CYP2C19 and CYP2D6 Gene Variants on Treatment with Antidepressants in Young People with Depression: A Danish Cohort Study.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: June 15, 2022

Dihydropyrimidine Dehydrogenase Phenotyping Using Pretreatment Uracil: A Note of Caution Based on a Large Prospective Clinical Study.

Dihydropyrimidine Dehydrogenase Phenotyping Using Pretreatment Uracil: A Note of Caution Based on a Large Prospective Clinical Study.

Journal: Clinical pharmacology and therapeutics

Published: February 22, 2022

Life-time Actionable Pharmacogenetic Drug Use: A Population-based Cohort Study in 86 040 Young People With and Without Mental Disorders in Denmark.

Life-time Actionable Pharmacogenetic Drug Use: A Population-based Cohort Study in 86 040 Young People With and Without Mental Disorders in Denmark.

Journal: Pharmacopsychiatry

Published: November 09, 2021

Pharmacogenetic genotype and phenotype frequencies in a large Danish population-based case-cohort sample.

Pharmacogenetic genotype and phenotype frequencies in a large Danish population-based case-cohort sample.

Journal: Translational psychiatry

Published: January 16, 2021

Pharmacogenetics in psychiatric care, a call for uptake of available applications.

Pharmacogenetics in psychiatric care, a call for uptake of available applications.

Journal: Psychiatry research

Published: May 22, 2020

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy: who and how? - Authors' reply.

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy: who and how? - Authors' reply.

Journal: The Lancet. Oncology

Published: January 03, 2019

Confirmation practice in pharmacogenetic testing; how good is good enough?

Confirmation practice in pharmacogenetic testing; how good is good enough?

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: December 20, 2018

Diagnostic and Therapeutic Strategies for Fluoropyrimidine Treatment of Patients Carrying Multiple DPYD Variants.

Diagnostic and Therapeutic Strategies for Fluoropyrimidine Treatment of Patients Carrying Multiple DPYD Variants.

Journal: Genes

Published: November 09, 2018

A cost analysis of upfront DPYD genotype-guided dose individualisation in fluoropyrimidine-based anticancer therapy.

A cost analysis of upfront DPYD genotype-guided dose individualisation in fluoropyrimidine-based anticancer therapy.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 25, 2018

Showing 1-12 of 18

Last Updated: 09/26/2026